Similarly, upregulation and non-enzymatic glycation of ACE2 in DM cardiomyocytes could increase the susceptibility of patients with DM to COVID-19 by favoring the cellular entry of SARS-CoV-2 [28]. The gene discussed is ACE2; the disease is COVID-19.